Blueprint Medicines collaborated with the Health Equity Emissary Team (HEET) of Diverse Health Hub to produce an in-person internal company-wide event during Core Values week.

Diversity in clinical trials benefits everyone in ways that cannot be overlooked. Here’s a look at some of the history that has led to distrust, the importance of clinical trial diversity, creating lifelines for marginalized patients, and helping patients to access tomorrow’s medicine today.

Decentralized clinical trials offer many advantages over traditional clinical trial models, but what are DCTs exactly? Here’s a look at clinical trials and BIPOC patients, DCTs, and what decentralized clinical trials can mean for BIPOC patients. 

Diversity in clinical trials has been a topic of interest at Diverse Health Hub (DHH). Increasing diversity in clinical trials helps investigators to further improve and refine treatments for underrepresented patient groups. Here’s a look at U.S. efforts for improvements in enhancing clinical trial diversity.

What have researchers learned about ancestry and the prevalence of cancer-associated genetic alterations? Here’s a look at some recent findings from the AACR Cancer Disparities Progress Report 2022.

This article provides an overview of the existence and role of racism in healthcare, how it manifests, and its negative impact on the healthcare of people in racial and ethnic groups — resulting in health disparities.

This article provides an overview of the existence and role of unconscious bias in healthcare, how it manifests, and its negative impact on the healthcare of people in racial and ethnic groups — resulting in health disparities.

PEN enlisted the HEET to conduct a high-level landscape analysis of PEN’s organization to identify how it could integrate Equity, Diversity, and Inclusivity into its values and actions.

Now, more than ever, the BIPOC community needs ways to work through life trauma. Enter the power of talk and other healing methods to cope with trauma to maintain mental health.